The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

Skip to main content

Primary Cutaneous Anaplastic Large Cell Lymphoma

Indolent CD30 positive skin lymphoma with favorable prognosis

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Hematoloji department. Book Appointment →

What is Primary Cutaneous Anaplastic Large Cell Lymphoma?

Primary cutaneous anaplastic large cell lymphoma belongs to the spectrum of CD30 positive cutaneous lymphoproliferative disorders together with lymphomatoid papulosis. It presents in adults as solitary or multifocal red purple nodules or tumors on the trunk, head, neck, or extremities with frequent ulceration but rare extracutaneous spread.

Histology shows sheets of large pleomorphic cells with abundant cytoplasm and irregular nuclei expressing CD30 in more than seventy five percent of tumor cells, often CD4 positive with variable cytotoxic markers. ALK protein is usually negative in contrast to systemic anaplastic large cell lymphoma. Spontaneous regression is common but relapses also occur.

Management depends on extent and includes radiotherapy or surgical excision for solitary lesions, low dose methotrexate for multifocal disease, and brentuximab vedotin for refractory or extensive cases. Multiagent chemotherapy is reserved for systemic progression. Long term skin surveillance is needed because of relapse and second malignancy risk.

Symptoms

Solitary or grouped red purple nodules
Frequent ulceration of skin lesions
Slow growth on trunk or extremities
Spontaneous regression in some cases
Local relapse without systemic spread

Risk Factors

Adult age at presentation
Underlying lymphomatoid papulosis
Chronic skin inflammation
Immunosuppression in some patients
Male predominance

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • When persistent skin nodule does not heal
  • When ulcerated tumor appears on skin
  • When new skin lesion develops in known disease
  • When systemic symptoms accompany skin disease
  • When lymph node involvement is suspected

Treatment Methods

01
Local radiotherapy for solitary lesion
02
Surgical excision when feasible
03
Low dose methotrexate weekly
04
Brentuximab vedotin for refractory disease
05
Topical or intralesional corticosteroids
06
Surveillance for systemic transformation
07
Multidisciplinary dermatology and oncology care

Which Department to Visit?

You can visit our Hematoloji department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Hematoloji Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.